Michael J. LaBarre

2021

In 2021, Michael J. LaBarre earned a total compensation of $2.3M as Senior Vice President, Chief Technical Officer at Halozyme Therapeutics, a 13% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$270,217
Option Awards$450,010
Salary$494,000
Stock Awards$1,050,040
Other$15,333
Total$2,279,600

LaBarre received $1.1M in stock awards, accounting for 46% of the total pay in 2021.

LaBarre also received $270.2K in non-equity incentive plan, $450K in option awards, $494K in salary and $15.3K in other compensation.

Rankings

In 2021, Michael J. LaBarre's compensation ranked 5,523rd out of 12,415 executives tracked by ExecPay. In other words, LaBarre earned more than 55.5% of executives.

ClassificationRankingPercentile
All
5,523
out of 12,415
56th
Division
Manufacturing
2,336
out of 5,505
58th
Major group
Chemicals And Allied Products
1,014
out of 2,375
57th
Industry group
Drugs
903
out of 2,096
57th
Industry
Biological Products, Except Diagnostic Substances
221
out of 449
51st

Pay ratio

Michael J. LaBarre's Pay$2,279,600
Median Employee's Pay$291,734
Pay Ratio

8

to 1

In 2021, the annual total compensation of Michael J. LaBarre was $2,279,600.

The annual total compensation of the median employee at Halozyme Therapeutics was $291,734.

The ratio of Michael J. LaBarre's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on March 25, 2022.

LaBarre's colleagues

We found three more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2021.

2021

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2021

Masaru Matsuda

Halozyme Therapeutics

General Counsel

2021

Elaine Sun

Halozyme Therapeutics

Chief Financial Officer

News

You may also like